Philip Rodrigs Shares Highlights of Raynar’s Largest Portfolio Holdings
Aug 10, 2020 22:29 pm UTC| Business
Raynar Portfolio Managements top ten holdings comprise big-name brands, including LoopUp, BigBlu Broadband, MaxCyte, and Avacta. Having identified a multitude of unexpected, high-conviction ideas, Philip Rodrigs is...

Hyundai's stock up 10.2% after divulging aim to capture 10% of EV sales with Ioniq brand
Aug 10, 2020 19:25 pm UTC| Business
South Korean automaker Hyundai Motor Co.s stock jumped as much as 10.2 percent after announcing plans to capture 10 percent of global electric vehicles (EVs) sales by 2025 through its new Ioniq brand. The stock price...

World's tallest prefab skyscrapers to rise in Singapore now being built in Malaysia
Aug 10, 2020 17:39 pm UTC| Business
A pair of 630-feet-tall skyscrapers set to rise in Singapore and become the tallest prefabricated buildings in the world are being built over the border in Malaysia. Dubbed the Avenue South Residences, the project will...

S. Korea aims to cut maritime accidents by 30% with marine navigation services
Aug 08, 2020 15:11 pm UTC| Business
South Koreas Ministry of Oceans and Fisheries (MOF) is targetting a 30 percent reduction in maritime accidents by utilizing a smart marine navigation system in offering the worlds first marine navigation services starting...

Korean Air inks deal to supply Kawasaki Heavy with aircraft parts
Aug 07, 2020 01:39 am UTC| Business
Korean Air Lines Co. inked an estimated US$299 million deal from Kawasaki Heavy Industries Ltd. to further supply the aft wheel well bulkhead component for B787 planes through 2030. The deal is an extension of a 2005...

Hyundai teams up with British firm to build urban air mobility infrastructure
Aug 07, 2020 01:33 am UTC| Business
Hyundai Motor Co. will work with British firm Urban-Air Port to build urban air mobility (UAM) infrastructure and recharging stations and conduct maintenance and repair works. The UAM is for handling takeoff and...

UK's AstraZeneca inks COVID-19 vaccine deal with China's Shenzhen Kangtai
Aug 07, 2020 01:30 am UTC| Business
British drugmaker AstraZeneca Plc announced that Shenzhen Kangtai Biological Products would produce its potential COVID-19 vaccine in mainland China. Under the agreement, Shenzhen Kangtai will ensure that it produces...
Tariff Tremors: Trump’s Greenland Fight Rattles Global Markets